Diginexs, Billion

Diginex's $1.5 Billion Resulticks Deal: Founder's $5.69 Bet vs. Market's $1.15 Reality

Veröffentlicht: 14.05.2026 um 21:12 Uhr, Redaktion boerse-global.de

Miles Pelham's $25.4M personal buy at $5.69 per share contrasts with stock at $1.20 amid Diginex's ambitious all-stock acquisition of Resulticks and severe dilution risk.

Diginex's $1.5 Billion Resulticks Deal: Founder's $5.69 Bet vs. Market's $1.15 Reality Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de
Diginex's $1.5 Billion Resulticks Deal: Founder's $5.69 Bet vs. Market's $1.15 Reality Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

Miles Pelham, founder of Diginex, has sunk $25.4 million of his own money into the company at an average price of $5.69 per share. The stock now trades at roughly $1.20, a 79% discount to his entry point. It is a stark illustration of the gulf between insider conviction and market sentiment as the technology firm pursues a transformative—and potentially dilutive—all-stock acquisition.

The target is Resulticks, an artificial-intelligence specialist in marketing technology and data analytics. Diginex plans to acquire it in a pure-equity transaction valued at around $1.5 billion. The long-stop date for closing has been pushed back to May 29, 2026, the company disclosed on May 14. That extension buys time but does not guarantee completion. For a buyer with a market capitalisation of just $34.92 million, the deal is orders of magnitude larger than the business that is doing the buying.

Diginex emphasises that it operates debt-free, a cushion that helps when structuring a share-based purchase. Still, the risk of severe dilution hangs over existing holders. The company itself acknowledges there is no assurance the transaction will close. If it falls through, attention will snap back to the standalone business, which posted revenue of $3.57 million in its latest period—up 203% year-on-year but still generating a net loss of $0.48 per share.

Should investors sell immediately? Or is it worth buying Diginex?

Since its initial public offering in January 2025, Diginex has spent more than $100 million on acquisitions to build scale. Three deals stand out: Matter DK for $13 million in October 2025, The Remedy Project for $7.6 million in January 2026, and Plan A for $80 million in February 2026. Each was meant to broaden the company’s software and data-infrastructure portfolio. A separate reseller agreement with Resulticks is expected to add $40 million in revenue over four years, suggesting commercial ties already exist.

The founder’s outsize personal investment at a price far above the current level sends a signal of long-term belief, but it has done little to stem the share slide. Since autumn, the stock has crashed more than 98%, touching a 52-week low of $1.15. Year-to-date the decline stands at roughly 96.4%. For the market, the dominant question is not ambition but execution. The May 29 deadline for the Resulticks deal is the next concrete checkpoint—and the clearest test yet of whether Diginex can match its founder’s conviction with a completed transaction.

Ad

Diginex Stock: New Analysis - 14 May

Fresh Diginex information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Diginex analysis...

Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.

en | KYG286871044 | DIGINEXS | boerse | 69337169 |